Lida M. Becerra

Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease

Adam Fleisher, Rema Raman, Eric Siemers et al. · Archives of Neurology · 2008 · 331 citations · Full text

Medicine, Neurology, Pharmacology +17

Variation in Complementary and Alternative Medicine (CAM) Use Across Racial/Ethnic Groups and the Development of Ethnic-Specific Measures of CAM Use

An‐Fu Hsiao, Mitchell D. Wong, Michael S. Goldstein et al. · The Journal of Alternative and Complementary Medicine · 2006 · 127 citations

Social Sciences, Ethnic Studies, Health Equity +9

Plasma Urate and Progression of Mild Cognitive Impairment

Michael C. Irizarry, Rema Raman, Michael A. Schwarzschild et al. · Neurodegenerative Diseases · 2008 · 86 citations · Full text

Medicine, Neurology, Pharmacology +17

Predicting the Onset of Glaucoma

Robert N. Weinreb, Linda M. Zangwill, Sonia Jain et al. · Ophthalmology · 2010 · 56 citations · Full text

Medicine, Ophthalmology, Vision Science +8

O1‐04‐03: The ADCS valproate neuroprotection trial: Primary efficacy and safety results

Pierre N. Tariot, Paul Aisen, Jeffrey L. Cummings et al. · Alzheimer s & Dementia · 2009 · 16 citations

Medicine, Neurology, Pharmacology +17